Weekly signal · RVMD · Healthcare

Revolution Medicines Inc (RVMD) carries a 96.2% 12-week surge into July

Momentum measures remain firm in weekly context, though lighter turnover leaves confirmation less complete.

Revolution Medicines Inc
Latest189.24 USD
1W move3.9%
Volume0.9x
TrendActive
Weekly market chart context for Revolution Medicines Inc, a biotechnology oncology company.

Market update

What happened

Revolution Medicines Inc (RVMD) closed the latest week at $189.24, up 3.9% for the week as the weekly price path over 52 weeks extended a larger biotech advance.

The move is supported by a 26.8% four-week gain, an active trend reading and Market Dynamics confirmation at 1.15. The complication is participation: weekly volume was 14.6 million shares versus a 16.8 million 13-week average.

Continue your research

Explore RVMD across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.Insider transactionsSee reported purchases and sales by company directors and executives.

RVMD coverage

Evidence context